This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rao TK et al. (1984) Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669–673
Rao TK et al. (1987) The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316: 1062–1068
Carbone L et al. (1989) Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 87: 389–395
Centers for Disease Control and Prevention (online 2 June 2006) Epidemiology of HIV/AIDS—United States, 1981–2005 [http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5521a2.htm] (accessed 31 July 2008)
Ifudu O et al. (1995) Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 15: 217–221
Michel C et al. (1992) Nephropathy associated with human immunodeficiency virus: a report on 11 cases including 6 treated with zidovudine. Nephron 62: 434–440
Szczech LA et al. (2002) Protease inhibitors are associated with a slowed progression of HIV-associated renal diseases. Clin Nephrol 57: 336–341
Winston JA et al. (2001) Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344: 1979–1984
Schwartz EJ et al. (2005) Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 16: 2412–2420
Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355: 2283–2296
Szczech LA et al. (2004) Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 39: 1199–1206
Szczech LA et al. (2004) The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66: 1145–1152
Dellow E et al. (1999) Protease inhibitor therapy for HIV infection: the effect on HIV-associated nephrotic syndrome. Nephrol Dial Transplant 14: 744–747
Winston JA et al. (1999) HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 55: 1036–1040
Hailemariam S et al. (2001) Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy. Swiss Med Wkly 131: 412–417
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author has declared associations with the following companies: GlaxoSmithKline, of whose speakers' bureau she is a member and from which she has grant support, and Gilead Sciences, of whose speakers' bureau she is a member and for which she acts as a consultant.
Rights and permissions
About this article
Cite this article
Szczech, L. HIV-related renal disease and the utility of empiric therapy—not everyone needs to be biopsied. Nat Rev Nephrol 5, 20–21 (2009). https://doi.org/10.1038/ncpneph0969
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0969
This article is cited by
-
Nierenerkrankungen bei HIV‑Infektion
Der Nephrologe (2020)
-
Renal abnormalities in a cohort of HIV-infected children and adolescents
Pediatric Nephrology (2016)